Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders' Equity (Deficiency)

v3.22.1
Consolidated Statements of Changes in Stockholders' Equity (Deficiency) - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at the beginning at Dec. 31, 2019 $ 36 $ 3,362,724 $ (8,403,417) $ (5,040,657)
Balance at the beginning (in shares) at Dec. 31, 2019 3,601,521      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock and warrants in initial public offering, net of issuance costs [1] $ 25 10,605,720   10,605,745
Issuance of common stock and warrants in initial public offering, net of issuance costs (in shares) [1] 2,500,000      
Conversion of notes payable and accrued interest into common stock and warrants $ 15 7,304,815   7,304,830
Conversion of notes payable and accrued interest into common stock and warrants (in shares) 1,461,090      
Conversion of notes payable and accrued interest into common stock $ 1 388,143   388,144
Conversion of notes payable and accrued interest into common stock (in shares) 94,223      
Issuance of common stock and warrants in follow-on public offering, net of issuance costs $ 41 18,889,872   18,889,913
Issuance of common stock and warrants in follow-on public offering, net of issuance costs (in shares) 4,058,822      
Stock-based compensation: Common stock   154,922   154,922
Stock-based compensation: Common stock (in shares) 38,433      
Stock-based compensation: Options   19,570   19,570
Forgiveness of accrued expenses by related party   33,738   33,738
Exercise of warrant   11,000   11,000
Exercise of warrant (in shares) 2,000      
Effect of reverse stock-split (in shares) 20      
Net loss     (7,885,660) (7,885,660)
Balance at the end at Dec. 31, 2020 $ 118 40,770,504 (16,289,077) 24,481,545
Balance at the end (in shares) at Dec. 31, 2020 11,756,109      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation: Common stock $ 3 993,044   993,047
Stock-based compensation: Common stock (in shares) 238,702      
Stock-based compensation: Options   23,390   23,390
Net loss     (10,291,713) (10,291,713)
Shares issued upon exercise of warrants, net of issuance costs $ 21 9,703,609   9,703,630
Shares issued upon exercise of warrants, net of issuance costs (in shares) 2,156,322      
Common stock issued upon exercise of options   8,361   8,361
Common stock issued upon exercise of options (in shares) 2,815      
Shares issued as partial consideration for intangible asset $ 1 531,999   532,000
Shares issued as partial consideration for intangible asset (in shares) 100,000      
Balance at the end at Dec. 31, 2021 $ 143 $ 52,030,907 $ (26,580,790) $ 25,450,260
Balance at the end (in shares) at Dec. 31, 2021 14,253,948      
[1] Includes gross proceeds of $12,503,750, less issuance costs of $1,898,005.